Sysmex (OTCMKTS:SSMXY – Get Free Report) updated its FY 2026 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.382-0.382 for the period, compared to the consensus EPS estimate of 0.440. Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its quarterly earnings data on Friday, August 7th. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. Sysmex Company Profile(Get Free Report)Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems.